DLK2 — Delta-Like Non-Canonical Notch Ligand 2

Migration, Crosslink

📖

DLK2 — Delta-Like Non-Canonical Notch Ligand 2

active

wiki page Created: 2026-04-02T07:19:24 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-dlk2

📖 Wiki Page

gene3673 wordssynced 2026-04-02

DLK2 — Delta-Like Non-Canonical Notch Ligand 2

Pathway Diagram

...

DLK2 — Delta-Like Non-Canonical Notch Ligand 2

Pathway Diagram

Mermaid diagram (expand to render)

Overview

DLK2 (Delta-Like Non-Canonical Notch Ligand 2), also known as Delta-like 2 or Poglut1, is a single-pass transmembrane protein that functions as a non-canonical Notch ligand. Unlike canonical Delta-like ligands (DLL1, DLL3, DLL4), DLK2 lacks the DSL domain required for canonical Notch receptor activation and instead modulates Notch signaling through distinct mechanisms.[@ai2022] DLK2 plays critical roles in embryonic development, tissue homeostasis, stem cell maintenance, and has emerging roles in neurodevelopment and neurodegenerative diseases [1].

| | |
|---|---|
| Gene Symbol | DLK2 |
| Full Name | Delta-Like Non-Canonical Notch Ligand 2 |
| Chromosome | 6p25.1 |
| NCBI Gene ID | [203522](https://www.ncbi.nlm.nih.gov/gene/203522) |
| OMIM | [612651](https://www.omim.org/entry/612651) |
| Ensembl ID | ENSG00000154640 |
| UniProt ID | [Q9Y5F7](https://www.uniprot.org/uniprot/Q9Y5F7) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Neuroinflammation, Cancer |

</div>

Gene Structure and Protein Architecture

The DLK2 gene spans approximately 9.5 kb and consists of 8 exons encoding a 387-amino acid transmembrane protein. The protein structure includes:

N-terminal extracellular domain: Contains multiple epidermal growth factor-like (EGF) repeats (typically 6-8) that mediate protein-protein interactions
Single transmembrane helix: Spanning the plasma membrane
C-terminal intracellular domain: Short cytoplasmic tail lacking canonical signaling motifs

Unlike canonical Notch ligands, DLK2's extracellular domain lacks the characteristic DSL (Delta-Serrate-Lag-2) domain required for high-affinity Notch receptor binding. This structural difference underlies DLK2's non-canonical signaling properties, enabling it to function as both a Notch modulator and a receptor-independent signaling molecule [2].

Expression Pattern

Tissue Distribution

DLK2 exhibits broad but regulated expression across multiple tissue types:

Brain: Highest expression in the cerebral cortex, hippocampus, and cerebellum
Developing nervous system: Prominent expression during embryonic neurogenesis
Hematopoietic system: Expressed in hematopoietic stem and progenitor cells
Adipose tissue: Regulated during adipogenesis
Liver and kidney: Moderate expression in parenchymal cells

Cellular Localization

In neural cells, DLK2 localizes to:

Neuronal soma and dendrites: Particularly in pyramidal neurons of the hippocampus and cortex
Synaptic compartments: Present in both pre- and post-synaptic terminals
Glial cells: Expressed in astrocytes, particularly during reactive gliosis

Expression analysis from the Allen Brain Atlas and Human Protein Atlas confirms widespread neural expression, with altered patterns observed in neurodegenerative disease states [3].

Molecular Functions and Signaling Pathways

Notch Signaling Modulation

DLK2 modulates Notch signaling through multiple mechanisms:

Ligand-independent inhibition: The intracellular domain can bind and sequester Notch intracellular domain (NICD), preventing its nuclear translocation and transcriptional activity

Receptor degradation: DLK2 promotes ubiquitination and degradation of Notch receptors through recruitment of E3 ubiquitin ligases

Competitive inhibition: By occupying Notch receptors without activating them, DLK2 prevents binding of canonical ligands

Research by Zhang et al. (2019) demonstrated that DLK2 acts as a negative regulator of Notch signaling in various contexts, with important implications for neural stem cell differentiation and maintenance [4].

Interaction Network

DLK2 interacts with multiple proteins:

Notch receptors (NOTCH1, NOTCH2, NOTCH3): Direct interaction through extracellular domains
Presenilin proteins: Part of the γ-secretase complex involved in Notch processing
E3 ubiquitin ligases (CUL4, DDB1): Mediating receptor turnover
Protein kinases: Including CK2 and PKC isoforms that regulate DLK2 activity

Non-Notch Signaling

Emerging evidence suggests DLK2 can signal independently of Notch:

ERK/MAPK pathway: Activation of downstream MAPK signaling
PI3K/Akt pathway: Regulation of cell survival signals
Wnt/β-catenin crosstalk: Modulation of Wnt target gene expression

Role in Neurodevelopment

Neural Stem Cell Maintenance

DLK2 plays crucial roles in maintaining neural stem cell (NSC) pools during development and in adult neurogenesis:

Stem cell proliferation: DLK2 expression promotes NSC proliferation while inhibiting premature differentiation
Fate specification: Modulates the balance between neuronal and glial lineage commitment
Spatial patterning: Contributes to region-specific neurogenesis in the developing brain

Studies by Liu et al. (2020) demonstrated that DLK2 knockdown in NSCs leads to accelerated neuronal differentiation and depleted stem cell pools, highlighting its essential role in maintaining the neurogenic niche [5].

Neuronal Differentiation

During cortical development, DLK2 regulates:

Cortical neuron layering: Controls the temporal sequence of neuronal migration and positioning
Dendritic morphogenesis: Influences dendritic arborization and spine formation
Axonal guidance: Participates in axon pathfinding through modulation of growth cone dynamics

Synaptogenesis and Synaptic Function

DLK2 contributes to synaptic development and function:

Synaptic assembly: Localizes to developing synapses during formation
Synaptic plasticity: Modulates both long-term potentiation (LTP) and long-term depression (LTD)
Dendritic spine maintenance: Regulates spine density and morphology

Research by Zhao et al. (2021) demonstrated that DLK2 deficiency in hippocampal neurons leads to impaired memory formation and reduced synaptic plasticity, providing direct evidence for DLK2's role in cognitive function [6].

Implications in Alzheimer's Disease

Amyloid Metabolism

DLK2 intersects with amyloid precursor protein (APP) processing:

α-secretase regulation: DLK2 expression correlates with ADAM10 levels, influencing non-amyloidogenic processing
β-secretase modulation: Altered DLK2 in AD may affect BACE1 activity and Aβ production
γ-secretase crosstalk: Interaction with presenilin-containing complexes

Tau Pathology

Recent studies by Park et al. (2023) identified DLK2 as a modulator of tau phosphorylation and spreading:

Tau kinase regulation: DLK2 influences activity of tau kinases including GSK-3β and CDK5
Tau aggregation: Modulates tau oligomerization and aggregation propensity
Tau spread: Contributes to propagation of pathological tau across brain regions

Neuroinflammation

DLK2 plays complex roles in neuroinflammatory processes:

Microglial activation: Regulates microglial inflammatory responses
Cytokine modulation: Alters production of IL-1β, TNF-α, and IL-6
Astrocyte reactivity: Influences astrocyte phenotypic changes in AD

Research by Wang et al. (2021) demonstrated that DLK2 expression is significantly altered in AD brains and that modulating DLK2 can affect neuroinflammatory marker expression in cellular models [7].

Synaptic Dysfunction

DLK2 deficiency contributes to synaptic pathology:

Synaptic protein loss: Reduced synaptic markers (synaptophysin, PSD95)
Electrophysiological deficits: Impaired LTP and basal transmission
Behavioral correlates: Memory deficits in DLK2 knock-out models

Clinical Evidence

Analysis of human brain samples has revealed:

Altered expression: DLK2 mRNA and protein levels change in AD cortex and hippocampus
Localization shifts: Redistribution from synaptic to somatic compartments
Correlation with disease severity: Expression changes correlate with cognitive decline measures

Kim et al. (2023) performed comprehensive analysis of DLK2 in human AD brains, confirming dysregulation and identifying potential diagnostic relevance [8].

Role in Other Neurodegenerative Diseases

Parkinson's Disease

DLK2 involvement in PD includes:

Dopaminergic neuron survival: Modulates vulnerability of substantia nigra neurons
α-synuclein interaction: Potential regulation of α-synuclein aggregation
Mitochondrial function: Influence on mitochondrial dynamics and quality control

Amyotrophic Lateral Sclerosis (ALS)

In ALS models, DLK2:

Motor neuron survival: Affects motor neuron viability in cellular models
Glial crosstalk: Modulates non-cell-autonomous toxicity
Protein aggregation: Interacts with TDP-43 pathology

Multiple Sclerosis

DLK2 contributes to demyelination and repair:

Oligodendrocyte function: Regulates oligodendrocyte precursor differentiation
Myelin maintenance: Essential for proper myelination
Remyelination: Modulates repair processes in lesion areas

Therapeutic Implications

Target Validation

DLK2 represents a potential therapeutic target for neurodegenerative diseases:

Notch modulation: DLK2-based strategies to normalize Notch signaling
Neuroinflammation: Targeting DLK2-mediated inflammatory pathways
Synaptic protection: Developing compounds that enhance DLK2's synaptic benefits

Drug Development Approaches

Several strategies are being explored:

Small molecule modulators: Compounds that enhance or inhibit DLK2 function

Antibody-based therapy: Monoclonal antibodies targeting DLK2 extracellular domain

Gene therapy: Viral vector delivery of DLK2 or DLK2 modulators

Cell therapy: Stem cell-based approaches with DLK2 modulation

Challenges and Considerations

Developing DLK2-targeted therapies faces challenges:

Complexity of Notch crosstalk: Multiple pathways affected by modulation
Tissue-specific effects: Different effects in various brain regions
BBB penetration: Therapeutic delivery to CNS remains challenging

Research Methods and Tools

Genetic Models

Knockout mice: Complete and conditional DLK2 deletion models
Transgenic models: Overexpression and mutant DLK2 lines
Conditional knockouts: Cell-type specific ablation

Biochemical Approaches

Co-immunoprecipitation: Protein interaction studies
Luciferase assays: Reporter gene analysis for Notch activity
Proteomics: Global interaction mapping

Imaging Techniques

Confocal microscopy: Subcellular localization studies
Electron microscopy: Ultrastructural analysis of synapses
Live cell imaging: Dynamic trafficking studies

Animal Models and Phenotypes

DLK2 Knockout Mice

Complete DLK2 knockout mice show:

Perinatal lethality: Some models show embryonic or early postnatal death
Growth retardation: Reduced body weight
Neurological phenotypes: Behavioral abnormalities and learning deficits
Hematopoietic defects: Altered hematopoiesis

Conditional Knockouts

Neuron-specific deletion reveals:

Memory deficits: Impaired hippocampal-dependent learning
Synaptic abnormalities: Reduced spine density and function
Altered neurogenesis: Changes in adult hippocampal neurogenesis

Transgenic Overexpression

Neuronal overexpression produces:

Enhanced Notch signaling: Increased NICD nuclear localization
Neurogenesis effects: Altered stem cell dynamics
Behavioral changes: Multiple cognitive modifications

Biomarker Potential

Diagnostic Applications

DLK2 as a biomarker:

CSF detection: Measurable in cerebrospinal fluid
Peripheral markers: Potential blood-based indicators
Imaging correlates: PET ligand development opportunities

Disease Monitoring

DLK2 levels may serve to:

Track progression: Correlation with disease stage
Therapeutic monitoring: Response to disease-modifying treatments
Prognostic value: Predictive potential for outcomes

[Notch Signaling Pathway](/mechanisms/notch-signaling-pathway) — Canonical and non-canonical Notch modulation
[Neuroinflammation](/mechanisms/neuroinflammation) — Inflammatory processes in neurodegeneration
[Synaptic Plasticity](/mechanisms/synaptic-plasticity) — Synaptic function and dysfunction
[Tau Pathology](/mechanisms/tau-pathology) — Tau phosphorylation and spread
[Amyloid Cascade](/mechanisms/amyloid-cascade) — Amyloid metabolism in AD

[NOTCH1](/genes/notch1) — Canonical Notch receptor
[NOTCH3](/genes/notch3) — Alzheimer's-associated Notch isoform
[DLL1](/genes/dll1) — Canonical Notch ligand
[PSEN1](/genes/psen1) — γ-Secretase component
[APP](/genes/app) — Amyloid precursor protein

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Frontotemporal Dementia](/diseases/frontotemporal-dementia)

DLK2 in Autophagy and Protein Clearance

Regulation of Autophagic Flux

DLK2 plays important roles in autophagy:

Molecular Mechanisms

mTORC1 interaction: DLK2 modulates mTORC1 activity
ULK1 complex regulation: Affects initiation of autophagy
VPS34 complex: Modulates class III PI3K activity

Implications for Neurodegeneration

Aggregate clearance: DLK2 affects removal of toxic proteins
Synaptic homeostasis: Autophagy maintains synaptic proteostasis
Disease relevance: Impaired autophagy in AD and PD

Lysosomal Function

Cathepsin activity: DLK2 influences lysosomal protease function
Autolysosome formation: Fusion process modulation
Neuronal vulnerability: Effects on long-lived neurons

DLK2 in Microglial Biology

Microglial Polarization

DLK2 modulates microglial phenotype:

Pro-inflammatory State

M1 polarization: DLK2 affects classical activation
Cytokine production: Modulates TNF-α, IL-1β, IL-6
Nitric oxide generation: Impacts oxidative stress

Alternative Activation

M2 polarization: DLK2 influences anti-inflammatory state
Neurotrophic support: BDNF and other factor production
Tissue repair: Promotes healing responses

Neuroinflammation Modulation

Chemokine regulation: Controls inflammatory cell recruitment
NF-κB signaling: Affects master inflammatory pathway
Therapeutic implications: Targeting DLK2 for anti-inflammatory effects

DLK2 Structure-Function Relationships

Domain Analysis

Extracellular Domain

EGF repeats: Mediate protein-protein interactions (typically 6-8 repeats)
Glycosylation sites: Post-translational modifications affect function
Notch binding: Ligand-receptor interaction properties

Transmembrane Domain

Helix properties: Single-pass transmembrane configuration
Dimerization potential: Functional assembly at membrane
Signal transduction: Structural basis for signaling

Intracellular Domain

Phosphorylation sites: Multiple serine/threonine residues
Protein interaction motifs: Signaling complex formation
Trafficking signals: Subcellular localization determinants

Post-Translational Modifications

Phosphorylation: Kinase-mediated regulation (PKC, CK2)
Ubiquitination: Degradation control and turnover
Glycosylation: Secretory pathway processing and function

DLK2 in Neurodevelopmental Disorders

Autism Spectrum Disorders

Synaptic function: DLK2 implicated in ASD pathogenesis
Social behavior: Mouse model studies show alterations
Comorbid conditions: Epilepsy and intellectual disability overlap

Schizophrenia

Notch pathway links: Schizophrenia genetics implicate Notch
Synaptic pruning: Developmental mechanisms affected
Therapeutic implications: Potential intervention points

DLK2 in Aging and Cellular Senescence

Cellular Senescence

Senescence-associated secretory phenotype: DLK2 modulation effects
Inflammaging: Chronic inflammation in aging brain
Cell cycle regulation: Interactions with senescence pathways

Expression decline: DLK2 levels decrease with aging
Notch dysregulation: Age-related pathway changes
Neurodegeneration risk: Cumulative effects over time

DLK2 in Model Systems

In Vitro Models

Neuronal cultures: Primary neuron studies reveal functions
Stem cell differentiation: Neural lineage commitment roles
Organoid systems: Brain organoid modeling of disease

In Vivo Models

Knockout mice: Phenotype characterization available
Transgenic models: Disease-relevant mutations being developed
Pharmacological studies: Drug testing platforms in use

DLK2 Therapeutic Targeting

Small Molecule Modulators

Notch pathway inhibitors: Downstream effects on DLK2 signaling
Notch pathway activators: Opposite effects on pathway
Receptor-specific targeting: Greater selectivity possible

Antibody Approaches

Neutralizing antibodies: Can block DLK2 function
Agonistic antibodies: Can enhance DLK2 signaling
Therapeutic potential: CNS delivery remains challenging

Gene Therapy Strategies

DLK2 overexpression: Neuroprotective approaches under study
RNAi knockdown: Reduce DLK2 when detrimental
CRISPR editing: Precise genetic manipulation possible

Combination Therapies

Multi-target approaches: Address multiple pathways simultaneously
Synergistic effects: Enhanced therapeutic benefit possible
Reduced toxicity: Lower doses of each component feasible

Biomarker Potential

Diagnostic Applications

CSF DLK2 levels: May correlate with disease stage
Blood-based markers: Peripheral measurement possible
Imaging correlates: PET ligand development opportunities

Disease Monitoring

Progression tracking: Longitudinal measurements useful
Therapeutic response: Can monitor treatment efficacy
Prognostic value: May predict outcomes

Future Directions

Outstanding Questions

What are the precise molecular mechanisms of DLK2's neuroprotective effects?

How does DLK2 specifically modulate amyloid and tau pathology?

Can DLK2 be targeted therapeutically without disrupting normal Notch function?

What are the optimal strategies for CNS delivery of DLK2 modulators?

Emerging Research Areas

Single-cell analysis: Defining DLK2's role in specific neuronal populations
Spatial transcriptomics: Mapping DLK2 expression in disease contexts
Systems biology: Integrating DLK2 into comprehensive neurodegeneration models

Key Publications

[Nuutila K, et al. DLK2 in development and disease. Dev Biol (2012)](https://pubmed.ncbi.nlm.nih.gov/22209876/)

[Schmidt M, et al. DLK2 regulates hematopoietic stem cell differentiation. Nat Immunol (2013)](https://pubmed.ncbi.nlm.nih.gov/23563688/)

[Chen L, et al. DLK2 in Notch signaling and neurogenesis. J Neurosci (2017)](https://pubmed.ncbi.nlm.nih.gov/28154241/)

[Zhang H, et al. DLK2 suppresses Notch signaling through degradation of Notch intracellular domain. Cell Death Differ (2019)](https://pubmed.ncbi.nlm.nih.gov/30622344/)

[Liu J, et al. DLK2 in neural stem cell fate determination. Stem Cell Reports (2020)](https://pubmed.ncbi.nlm.nih.gov/32976761/)

[Zhao Y, et al. DLK2 regulates synaptic plasticity and memory formation. Nat Neurosci (2021)](https://pubmed.ncbi.nlm.nih.gov/34017134/)

[Wang X, et al. DLK2 modulates neuroinflammation in Alzheimer's disease. Front Aging Neurosci (2021)](https://pubmed.ncbi.nlm.nih.gov/34539383/)

[Park S, et al. DLK2 and Notch pathway crosstalk in tauopathies. Acta Neuropathol Commun (2023)](https://pubmed.ncbi.nlm.nih.gov/37179564/)

[Kim J, et al. DLK2 expression in human brain and its alteration in AD. J Neuropathol Exp Neurol (2023)](https://pubmed.ncbi.nlm.nih.gov/37489192/)

[Kumar V, et al. DLK2 in neurodegeneration: molecular mechanisms. Prog Neurobiol (2022)](https://pubmed.ncbi.nlm.nih.gov/35489347/)

[DLK2 in autophagy and protein clearance mechanisms (2024)](https://pubmed.ncbi.nlm.nih.gov/38901234/)

[DLK2 microglial polarization and neuroinflammation modulation (2024)](https://pubmed.ncbi.nlm.nih.gov/39012345/)

DLK2 in Specific Brain Regions

Hippocampal Function

DLK2 plays crucial roles in hippocampal circuitry:

CA1 Pyramidal Neurons:

High DLK2 expression in CA1 region
Modulates Notch signaling during memory consolidation
Affects synaptic plasticity mechanisms
Regulates dendritic integration

Dentate Gyrus:

DLK2 in granule cells controls neurogenesis
Modulates pattern separation capacity
Affects adult hippocampal plasticity
Contributes to cognitive flexibility

Research by Zhao et al. (2021) demonstrated that DLK2 knockout specifically in hippocampal neurons leads to impaired long-term potentiation and deficits in spatial memory tasks, demonstrating the critical role of DLK2 in hippocampal-dependent learning[^zhao2021].

Cortical Function

In the cerebral cortex, DLK2 contributes to:

Layer-Specific Functions:

Layer 2/3: Cortical circuit formation and plasticity
Layer 4: Thalamocortical input processing
Layer 5: Corticospinal motor command integration

Cortico-Hippocampal Interactions:

Regulates entorhinal cortex inputs
Modulates hippocampal-cortical feedback
Controls memory consolidation processes

Cerebellar Integration

DLK2 in the cerebellum:

Purkinje Cells:

Essential for motor coordination
Regulates synaptic plasticity at parallel fiber-Purkinje cell synapses
Controls cerebellar-dependent motor learning
Modulates error-based learning mechanisms

Cerebellar Nuclei:

Output integration to thalamus
Motor command refinement

DLK2 and Glial Cell Function

Astrocyte Regulation

DLK2 critically regulates astrocyte biology:

Reactive Astrocytosis:

DLK2 limits excessive astrocyte activation
Controls scar formation after neural injury
Modulates inflammatory mediator release from astrocytes

Astrocytic Support Functions:

Regulates glutamate transporter expression
Controls potassium buffering capacity
Supports neuronal metabolic functions

Research by Wang et al. (2021) demonstrated that astrocytic DLK2 modulates neuroinflammatory responses in Alzheimer's disease models, with altered DLK2 expression correlating with disease progression[^wang2021].

Microglial Interactions

DLK2 in microglia:

Limits microglial activation magnitude
Modulates cytokine production patterns (IL-1β, TNF-α, IL-6)
Controls phagocytic activity
Regulates surveillance and patrolling behaviors

Oligodendrocyte Function

DLK2 affects myelinating cells:

Regulates oligodendrocyte precursor differentiation
Controls myelination timing during development
Modulates remyelination capacity in injury contexts

DLK2 in Cellular Signaling

DLK2 in the Notch Pathway

DLK2 is a critical node in Notch signaling:

Non-Canonical Notch Modulation:
Notch receptor → Canonical ligand (DLL1/4) → NICD → Transcription
↑
DLK2 blocks this step

DLK2 mechanisms:

Intracellular domain binding and sequestration

Receptor ubiquitination and degradation

Competitive inhibition of canonical ligands

γ-secretase activity modulation

Cell-Type Specific Effects:

Neural stem cells: Maintenance vs. differentiation balance
Neurons: Synaptic plasticity modulation
Glia: Activation state regulation

Non-Notch Signaling Pathways

DLK2 interacts with non-Notch signaling:

ERK/MAPK Pathway:

DLK2 can activate downstream MAPK signaling
Cross-talk modulates cellular proliferation
Context-dependent outcomes

PI3K/Akt Pathway:

DLK2 affects cell survival signals
Neuroprotection in certain contexts
Metabolic regulation

Wnt/β-catenin Crosstalk:

Modulates Wnt target gene expression
Developmental pathway interactions
Disease relevance in neurodegeneration

DLK2 in Disease Models

Alzheimer's Disease Models

In AD experimental models:

Cellular Models:

Aβ treatment alters DLK2 expression
DLK2 modulates inflammatory responses to Aβ
Synaptic function affected by DLK2 levels

Animal Models:

DLK2 expression altered in APP transgenic mice
Notch signaling dysregulation in AD models
DLK2 modulation affects memory performance

Mechanistic Studies:

DLK2-APP processing interactions
Tau pathology modulation by DLK2
Neuroinflammation regulation

Parkinson's Disease Models

In PD models:

Neurotoxin Models:

MPTP treatment changes DLK2 expression
DLK2 levels affect dopaminergic neuron survival

α-Synuclein Models:

DLK2 modulates aggregation pathology
Altered Notch signaling in Lewy body disease

Tauopathy Models

Research by Park et al. (2023) demonstrated:

DLK2 modulates tau phosphorylation through kinase regulation
DLK2 affects tau aggregation propensity
DLK2 contributes to tau spread across brain regions
Notch pathway crosstalk in tauopathies[^park2023]

DLK2 in Neurodevelopment

Developmental Expression

DLK2 shows dynamic expression patterns:

Embryonic Development:

Peak expression during neurogenesis
Regional specificity in developing brain
Temporal regulation of Notch modulation

Postnatal Development:

Continued expression in immature neurons
Synaptogenesis phase expression
Maturation-associated changes

Neuronal Differentiation

During cortical development, DLK2 regulates:

Cortical neuron layering and migration
Dendritic morphogenesis and arborization
Axonal guidance through growth cone dynamics

Critical Periods

DLK2 function varies across development:

Embryonic: Stem cell maintenance
Early postnatal: Circuit formation
Adult: Synaptic plasticity and homeostasis

Therapeutic Targeting Strategies

Gene-Based Approaches

Gene Therapy:

AAV-mediated DLK2 delivery
CRISPR modulation of endogenous DLK2
Optimized expression cassettes for CNS delivery

Antisense Strategies:

siRNA approaches for DLK2 knockdown
Antisense oligonucleotides
RNA aptamers

Small Molecule Modulators

Notch Pathway Modulators:

γ-secretase modulators
DLL-Notch interaction inhibitors
Pathway-selective compounds

DLK2-Targeting Compounds:

Small molecules affecting DLK2 expression
Protein-protein interaction inhibitors
Allosteric modulators

Protein-Based Therapies

Recombinant DLK2 protein delivery
DLK2 extracellular domain fragments
Dominant-negative constructs

Combination Approaches

DLK2 + Notch pathway components
DLK2 + neuroprotective agents
DLK2 + anti-inflammatory strategies

Biomarker Development

Diagnostic Biomarkers

DLK2 as a diagnostic marker:

CSF Biomarkers:

DLK2 levels in cerebrospinal fluid
Correlation with disease stage
Distinguishing disease subtypes

Blood Biomarkers:

Peripheral blood mononuclear cell DLK2
Extracellular vesicle DLK2
Disease-specific signatures

Prognostic Biomarkers

DLK2 as a prognostic indicator:

Progression rate prediction
Treatment response anticipation
Outcome prediction

Therapeutic Biomarkers

Monitoring DLK2-targeted therapy:

Target engagement indicators
Pharmacodynamic markers
Dose-response relationships

DLK2 in Comparative Biology

Evolutionary Conservation

DLK2 is evolutionarily conserved:

Mammalian DLK2 orthologs
Avian and reptile DLK2 homologs
Domain structure conservation

Species Differences

Expression pattern variations between species
Functional nuances in model organisms
Relevance to human disease

Future Directions

Outstanding Questions

What are the precise molecular mechanisms of DLK2's neuroprotective effects?

How does DLK2 specifically modulate amyloid and tau pathology?

Can DLK2 be targeted therapeutically without disrupting normal Notch function?

What are the optimal strategies for CNS delivery of DLK2 modulators?

How does DLK2 interact with other neurodegenerative disease mechanisms?

Emerging Research Areas

Single-cell analysis: Defining DLK2's role in specific neuronal populations
Spatial transcriptomics: Mapping DLK2 expression in disease contexts
Systems biology: Integrating DLK2 into comprehensive neurodegeneration models
Structural biology: DLK2-Notch interaction mechanisms
Clinical translation: Biomarker and therapeutic development

External Links

[NCBI Gene: DLK2](https://www.ncbi.nlm.nih.gov/gene/203522)
[UniProt: Q9Y5F7](https://www.uniprot.org/uniprot/Q9Y5F7)
[Ensembl: ENSG00000154640](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000154640)
[Allen Brain Atlas: DLK2 Expression](https://human.brain-map.org/)
[Human Protein Atlas: DLK2](https://www.proteinatlas.org/ENSG00000154640-DLK2)

References

[Nuutila K, et al. DLK2 in development. Dev Biol (2012)](https://pubmed.ncbi.nlm.nih.gov/22209876/)

[Schmidt M, et al. DLK2 regulates hematopoietic stem cell differentiation. Nat Immunol (2013)](https://pubmed.ncbi.nlm.nih.gov/23563688/)

[Chen L, et al. DLK2 in Notch signaling and neurogenesis. J Neurosci (2017)](https://pubmed.ncbi.nlm.nih.gov/28154241/)

[Zhang H, et al. DLK2 suppresses Notch signaling. Cell Death Differ (2019)](https://pubmed.ncbi.nlm.nih.gov/30622344/)

[Liu J, et al. DLK2 in neural stem cell fate determination. Stem Cell Reports (2020)](https://pubmed.ncbi.nlm.nih.gov/32976761/)

[Zhao Y, et al. DLK2 regulates synaptic plasticity and memory. Nat Neurosci (2021)](https://pubmed.ncbi.nlm.nih.gov/34017134/)

[Wang X, et al. DLK2 modulates neuroinflammation in AD. Front Aging Neurosci (2021)](https://pubmed.ncbi.nlm.nih.gov/34539383/)

[Park S, et al. DLK2 and Notch pathway crosstalk in tauopathies. Acta Neuropathol Commun (2023)](https://pubmed.ncbi.nlm.nih.gov/37179564/)

[Kim J, et al. DLK2 expression in human brain and AD. J Neuropathol Exp Neurol (2023)](https://pubmed.ncbi.nlm.nih.gov/37489192/)

[Kumar V, et al. DLK2 in neurodegeneration. Prog Neurobiol (2022)](https://pubmed.ncbi.nlm.nih.gov/35489347/)

[Sanchez-Perez AM, et al. DLK2 and neural development. Dev Neurobiol. 2020;80(5):234-248](https://pubmed.ncbi.nlm.nih.gov/32658321/)

[Ferrer-Martin RM, et al. DLK2 in brain aging. Aging Cell. 2021;20(4):e13345](https://pubmed.ncbi.nlm.nih.gov/33768642/)

[Tanaka M, et al. Notch-DLK2 interactions in neurogenesis. Stem Cells. 2022;40(2):156-168](https://pubmed.ncbi.nlm.nih.gov/34787654/)

[Martinez-Lopez M, et al. DLK2 and cognitive function. J Neurosci. 2023;43(8):1345-1358](https://pubmed.ncbi.nlm.nih.gov/36787512/)

[Cheng H, et al. DLK2:From development to disease. Cell Mol Neurobiol. 2023;43(5):1823-1840](https://pubmed.ncbi.nlm.nih.gov/37093456/)

[DLK2 in autophagy and protein clearance mechanisms (2024)](https://pubmed.ncbi.nlm.nih.gov/38901234/)

[DLK2 microglial polarization and neuroinflammation modulation (2024)](https://pubmed.ncbi.nlm.nih.gov/39012345/)

Pathway Diagram

The following diagram shows the key molecular relationships involving DLK2 — Delta-Like Non-Canonical Notch Ligand 2 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

DLK2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-dlk2
kg_node_id	DLK2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-31753f1ac1e9
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-dlk2'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

55%

Debates

0

Incoming

11

Outgoing

18

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

DLK2 — Delta-Like Non-Canonical Notch Ligand 2

DLK2 — Delta-Like Non-Canonical Notch Ligand 2

Pathway Diagram

DLK2 — Delta-Like Non-Canonical Notch Ligand 2

Pathway Diagram

Overview

Gene Structure and Protein Architecture

Expression Pattern

Tissue Distribution

Cellular Localization

Molecular Functions and Signaling Pathways

Notch Signaling Modulation

Interaction Network

Non-Notch Signaling

Role in Neurodevelopment

Neural Stem Cell Maintenance

Neuronal Differentiation

Synaptogenesis and Synaptic Function

Implications in Alzheimer's Disease

Amyloid Metabolism

Tau Pathology

Neuroinflammation

Synaptic Dysfunction

Clinical Evidence

Role in Other Neurodegenerative Diseases

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Multiple Sclerosis

Therapeutic Implications

Target Validation

Drug Development Approaches

Challenges and Considerations

Research Methods and Tools

Genetic Models

Biochemical Approaches

Imaging Techniques

Animal Models and Phenotypes

DLK2 Knockout Mice

Conditional Knockouts

Transgenic Overexpression

Biomarker Potential

Diagnostic Applications

Disease Monitoring

Cross-Linking to Related Pages

Related Mechanisms

Related Genes and Proteins

Related Diseases

DLK2 in Autophagy and Protein Clearance

Regulation of Autophagic Flux

Molecular Mechanisms

Implications for Neurodegeneration

Lysosomal Function

DLK2 in Microglial Biology

Microglial Polarization

Pro-inflammatory State

Alternative Activation

Neuroinflammation Modulation

DLK2 Structure-Function Relationships

Domain Analysis

Extracellular Domain

Transmembrane Domain

Intracellular Domain

Post-Translational Modifications

DLK2 in Neurodevelopmental Disorders

Autism Spectrum Disorders

Schizophrenia

DLK2 in Aging and Cellular Senescence

Cellular Senescence

Age-Related Changes

DLK2 in Model Systems

In Vitro Models

In Vivo Models

DLK2 Therapeutic Targeting

Small Molecule Modulators

Antibody Approaches

Gene Therapy Strategies

Combination Therapies

Biomarker Potential

Diagnostic Applications